Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterActive in the last 2 years

Jennifer B. Permuth

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4726-9264; OpenAlex author ID A5037680432; NIH RePORTER profile ID 14313408. Sources: ClinicalTrials.gov.

Their work

Papers
37 (first author 1, last author 5)
Trials
4 (principal investigator on 4)
Grants
1
Labs led
1
Collaborators
142
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 3 papers · 2019: 2 papers, 1 trial · 2020: 1 paper, 1 trial · 2021: 4 papers · 2022: 6 papers · 2023: 2 papers, 1 trial · 2024: 4 papers · 2025: 6 papers, 1 trial, 1 grant · 2026: 7 papers

Papers 37

  1. Pancreatic Cancer Early Detection Biomarkers for High-Risk Individuals: Insights From the PRECEDE Consortium. Co-author DOI 10.1002/ijc.70592↗
  2. Ratiometric Fluorescent Chemosensing for Predicting Response to Irinotecan-Based Therapies in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1021/acssensors.5c04552↗
  3. Implementing Timely Germline Genetic Testing for Patients With Pancreatic Cancer Using a Genetics Copilot for Point-of-Care Education and Health Assessment. Last author DOI 10.1200/po-25-00807↗
  4. Dynamic tumor tracking for locally advanced pancreatic cancer: precision in motion. First author DOI 10.21037/tcr-2026-0588↗
  5. Reframing pancreatic cancer diagnosis: metabolic signatures and the challenge of rule-out testing. Last author DOI 10.21037/tgh-2026-0045↗
  6. Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals Co-author DOI 10.64898/2026.04.21.26351329↗
  7. The impact of neighborhood socioeconomic deprivation on metastatic pancreatic cancer treatment and survival: An incidence-based, causally-structured observatio… Co-author DOI 10.64898/2026.08.06.26359821↗
  8. Early Supportive and Nutritional Care For Adults With Pancreatic Cancer: A Pilot Study. Co-author DOI 10.1016/j.jpainsymman.2025.07.032↗
  9. Race-based differences in serum biomarkers for cancer-associated cachexia in a diverse cohort of patients with pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s43856-025-01277-9↗
  10. The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1055-9965.epi-25-0237↗
  11. Lifetime stressor exposure and depression among patients with pancreatic cancer: insights from the Florida Pancreas Collaborative. Last author DOI 10.1186/s12885-025-15007-w↗
  12. Areas of Uncertainty in Pancreatic Cancer Surveillance: A Survey Across the International Pancreatic Cancer Early Detection (PRECEDE) Consortium. Co-author DOI 10.1200/po-25-00696↗
  13. Influence of Coping, Esteem, and Resilience on Caregiver Distress in Pancreatic Cancer Patient-Caregiver Dyads. Co-author DOI 10.3390/healthcare13020114↗
  14. Elevated Urinary Levels of Fungal and Environmental Toxins in Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1007/s12029-024-01125-4↗
  15. Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of t… Co-author DOI 10.3389/fonc.2024.1362244↗
  16. Pancreatic Ductal Adenocarcinoma (PDAC): A Review of Recent Advancements Enabled by Artificial Intelligence. Co-author DOI 10.3390/cancers16122240↗
  17. The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals. Co-author DOI 10.6004/jnccn.2023.7097↗
  18. The impact of age and comorbidity on localized pancreatic cancer outcomes: A US retrospective cohort analysis with implications for surgical centralization. Co-author DOI 10.1016/j.sopen.2023.02.001↗
  19. Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance. Co-author DOI 10.1158/1940-6207.capr-22-0529↗
  20. Patient-caregiver dyads in pancreatic cancer: identification of patient and caregiver factors associated with caregiver well-being. Co-author DOI 10.1007/s10865-022-00354-x↗
  21. Standardization of EUS imaging and reporting in high-risk individuals of pancreatic adenocarcinoma: consensus statement of the Pancreatic Cancer Early Detectio… Co-author DOI 10.1016/j.gie.2021.10.025↗
  22. A comparative Proteomics Analysis Identified Differentially Expressed Proteins in Pancreatic Cancer-Associated Stellate Cell Small Extracellular Vesicles. Co-author DOI 10.1016/j.mcpro.2022.100438↗
  23. A whole-exome case-control association study to characterize the contribution of rare coding variation to pancreatic cancer risk. Co-author DOI 10.1016/j.xhgg.2021.100078↗
  24. A Path Forward for Understanding and Addressing Multifaceted Pancreatic Cancer Disparities. Co-author DOI 10.1053/j.gastro.2022.04.047↗
  25. Hospital Surgical Volume Is Poorly Correlated With Delivery of Multimodal Treatment for Localized Pancreatic Cancer: A National Retrospective Cohort Study. Co-author DOI 10.1097/as9.0000000000000197↗
  26. Recommendations for a More Organized and Effective Approach to the Early Detection of Pancreatic Cancer From the PRECEDE (Pancreatic Cancer Early Detection) Co… Co-author DOI 10.1053/j.gastro.2021.08.036↗
  27. A Case Control Study of the Seroprevalence of Helicobacter pylori Proteins and Their Association with Pancreatic Cancer Risk. Co-author DOI 10.1089/pancan.2021.0010↗
  28. The Impact of Socioeconomic Deprivation on Clinical Outcomes for Pancreatic Adenocarcinoma at a High-volume Cancer Center: A Retrospective Cohort Analysis. Co-author DOI 10.1097/sla.0000000000003706↗
  29. The Florida Pancreas Collaborative Next-Generation Biobank: Infrastructure to Reduce Disparities and Improve Survival for a Diverse Cohort of Patients with Pan… Co-author DOI 10.3390/cancers13040809↗
  30. Disparities in Pancreatic Ductal Adenocarcinoma-The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes. Co-author DOI 10.1002/cam4.3042↗
  31. Racial and ethnic disparities in a state-wide registry of patients with pancreatic cancer and an exploratory investigation of cancer cachexia as a contributor … Co-author DOI 10.1002/cam4.2180↗
  32. Characteristics and Clinical Outcomes of Individuals at High Risk for Pancreatic Cancer: A Descriptive Analysis from a Comprehensive Cancer Center. Last author DOI 10.3390/gidisord1010008↗
  33. CDKN2A Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority Populations. Co-author DOI 10.1158/1055-9965.epi-17-1065↗
  34. Pancreatic Cancer Related Health Disparities: A Commentary. Co-author DOI 10.3390/cancers10070235↗
  35. Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine. Co-author DOI 10.3390/ijms19123836↗
  36. Partnering to Advance Early Detection and Prevention Efforts for Pancreatic Cancer: The Florida Pancreas Collaborative Co-author DOI 10.2217/fon-2016-0045↗
  37. miRNAs As Biomarkers of High-Risk Pancreatic Cysts: A Possible Holy Grail for the Early Detection of Pancreatic Cancer Co-author DOI 10.2217/fon.15.230↗

Trials 4

  1. Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception Center Principal investigator NCT06712797↗
  2. Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations Principal investigator NCT05687188↗
  3. Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas Principal investigator NCT04275557↗
  4. Florida Pancreas Collaborative Next Generation Biobank Principal investigator NCT03851133↗

Grants 1

  1. Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology R37CA229810↗

Closest collaborators

The 25 strongest of 142 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mokenge Peter Malafa · 10 shared papers, 1 shared trial, 2015–2026 · strength 2.00
  2. Pamela Joy Hodul · 11 shared papers, 2019–2026 · strength 1.83
  3. Daniel K. Jeong · 5 shared papers, 1 shared grant, 2019–2025 · strength 1.79
  4. Jason B. Fleming · 10 shared papers, 2019–2026 · strength 1.66
  5. Benjamin Daniel Powers · 6 shared papers, 2019–2026 · strength 1.02
  6. José M. Pimiento · 6 shared papers, 2021–2025 · strength 0.91
  7. Sarah E. Hoffe · 3 shared papers, 2025–2026 · strength 0.83
  8. Margaret A. Park · 4 shared papers, 2024–2025 · strength 0.76
  9. Dae Won Kim · 4 shared papers, 2023–2026 · strength 0.75
  10. Evan W. Davis · 3 shared papers, 2025–2026 · strength 0.70
  11. Daniel A. Anaya · 4 shared papers, 2021–2026 · strength 0.69
  12. Nicole Nardella · 3 shared papers, 2025–2026 · strength 0.65
  13. Jose Gilberto Trevino · 6 shared papers, 2016–2025 · strength 0.64
  14. Nipun B. Merchant · 6 shared papers, 2016–2025 · strength 0.63
  15. Diane M. Simeone · 4 shared papers, 2021–2026 · strength 0.57
  16. George Zogopoulos · 4 shared papers, 2021–2026 · strength 0.57
  17. Ghulam Rasool · 3 shared papers, 2024–2025 · strength 0.57
  18. Dung‐Tsa Chen · 4 shared papers, 2019–2025 · strength 0.55
  19. Kelvin Allenson · 3 shared papers, 2022–2025 · strength 0.55
  20. Dae Won Kim · 3 shared papers, 2022–2025 · strength 0.53
  21. Vic Velanovich · 3 shared papers, 2025 · strength 0.50
  22. Randall E. Brand · 3 shared papers, 2023–2026 · strength 0.49
  23. Julie Earl · 3 shared papers, 2023–2026 · strength 0.49
  24. Paul A. Stewart · 3 shared papers, 2022–2025 · strength 0.45
  25. Andrew R. Judge · 4 shared papers, 2018–2025 · strength 0.45

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.